Sanjay Chandrasekaran, M.D.

Harold C. Simmons Comprehensive Cancer Center

Eugene P. Frenkel, M.D. Scholar in Clinical Medicine

Internal Medicine - Hematology/Oncology
Advanced skin cancer
Melanoma

New Patient Appointment Accepting Virtual Visits or 214-645-4673

Biography

Sanjay Chandrasekaran, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in hematology and oncology, with a focus on melanoma, advanced skin cancer, and soft tissue and bone sarcomas.

Dr. Chandrasekaran earned his medical degree at the University of Washington School of Medicine. He completed joint residency and advanced fellowship training in internal medicine, hematology, and medical oncology through the physician-scientist pathway at Emory University and its Winship Cancer Institute.

Certified by the American Board of Internal Medicine, Dr. Chandrasekaran joined the UT Southwestern faculty in 2021.

He is a member of several professional associations, including the American Society of Clinical Oncology (ASCO) and the American Medical Association.

He has published numerous academic articles, delivered multiple presentations, and served as a grant reviewer for the When Everyone Survives Leukemia Research Foundation.

During fellowship training, Dr. Chandrasekaran received a Conquer Cancer Foundation of ASCO Merit Award and was the recipient of the 2020 Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group’s Paul Carbone, MD Fellowship Award.

Education & Training

Fellowship - Emory University School of Medicine - Emory Winship Cancer Institute (2016-2021), Hematology Oncology
Residency - Emory University School of Medicine (2014-2016), Internal Medicine
Medical School - University of Washington (2009-2014)

Professional Associations & Affiliations

American College of Physicians
American Medical Association
American Society of Clinical Oncology
American Association for Cancer Research
Society for Immunotherapy of Cancer

Honors & Awards

Paul Carbone, MD Fellowship Award 2020, ECOG-ACRIN Cancer Research Group
Merit Award 2019, Conquer Cancer Foundation of American Society of Clinical Oncology
Postdoctoral Fellow 2017-2020, National Institutes of Health/National Research Service Award (NIH/NRSA) T32 (5CA160040)
Elkin Fellowship Award 2017-2018, Winship Cancer Institute of Emory University

Books & Publications

Publications
- 20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment.
  Chandrasekaran S, Lawson DH, Annals of translational medicine 2020 Jun 8 12 776
- Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
  Chandrasekaran S, Sasaki M, Scharer CD, Kissick HT, Patterson DG, Magliocca KR, Seykora JT, Sapkota B, Gutman DA, Cooper LA, Lesinski GB, Waller EK, Thomas SN, Kotenko SV, Boss JM, Moreno CS, Swerlick RA, Pollack BP, Molecular cancer research : MCR 2019 12 17 12 2395-2409
- Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
  Ju M, Kao GD, Steinmetz D, Chandrasekaran S, Keefe SM, Guzzo TJ, Christodouleas JP, Hahn SM, Dorsey JF, Cancer biology & therapy 2014 Jun 15 6 683-7
- Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.
  Macarthur KM, Kao GD, Chandrasekaran S, Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM, Dorsey JF, Cancer research 2014 Apr 74 8 2152-9
- 18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
  Chandrasekaran S, Hollander A, Xu X, Benci JL, Davis JJ, Dorsey JF, Kao G, TheScientificWorldJournal 2013 2013 796029
- An integrated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain tumors using the small animal radiation research platform.
  Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, Kao GD, Dorsey JF, Translational oncology 2012 Aug 5 4 230-7
- Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.
  Cengel KA, Voong KR, Chandrasekaran S, Maggiorella L, Brunner TB, Stanbridge E, Kao GD, McKenna WG, Bernhard EJ, Neoplasia (New York, N.Y.) 2007 Apr 9 4 341-8

Research

Immunotherapy resistance
Clinical toxicity of checkpoint inhibitor therapy
Cancer Immunology
PI3K signaling

Clinical Focus

Advanced skin cancer
Melanoma
Soft tissue and bone sarcomas
Ocular oncology
Uveal melanoma